Check out our most popular compounded medications! Get Started
Papaverine HCl 300 mg Slow Release Capsules are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used to treat conditions such as erectile dysfunction, Raynaud's syndrome, intermittent claudication, Peyronie's disease, and priapism.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Papaverine HCl 300 mg Slow Release Capsules is a specialized prescription medication, primarily used in the treatment of conditions such as erectile dysfunction, peripheral vascular disease, and Raynaud's phenomenon. This unique formulation incorporates Methocel E4M, a controlled-release polymer, which is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
The slow and sustained release of the active ingredient, papaverine hydrochloride, allows for a more consistent therapeutic effect. This controlled and prolonged release profile not only offers sustained therapeutic effects but also reduces the dosing frequency, thereby improving patient compliance. This is particularly beneficial for medications that require a controlled release profile for optimal effectiveness.
The recommended dosage for this formulation is one capsule taken orally once daily. It is advised to take the capsule with food to minimize the risk of gastrointestinal side effects. Some common side effects associated with this medication include nausea, headache, dizziness, and flushing. Patients are encouraged to contact their healthcare provider if they experience any of these side effects or if they have any questions or concerns about the medication.
It can provide significant relief for patients suffering from erectile dysfunction, peripheral vascular disease, and Raynaud's phenomenon. For any further queries about this formulation, please do not hesitate to contact us at Bayview Pharmacy.
Papaverine HCl 300 mg Slow Release Capsules are a compounded formulation designed to provide a controlled and prolonged release of the active ingredient. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled release profile.
It's important to note that Papaverine HCl 300 mg Slow Release Capsules may interact with other medications. This includes medications used to treat hypertension, angina, and erectile dysfunction. Therefore, patients are advised to inform their healthcare provider of all medications they are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements. Additionally, patients should disclose any other medical conditions they may have, as well as any known allergies to medications.
Patients taking Papaverine HCl 300 mg Slow Release Capsules should be aware of potential side effects, which may include drowsiness, dizziness, or lightheadedness. As a result, patients are advised not to drive or operate machinery until they understand how the medication affects them. It's also recommended that patients avoid alcohol while taking this medication.
Overall, while Papaverine HCl 300 mg Slow Release Capsules offer a number of benefits, it's crucial that patients communicate openly with their healthcare provider to ensure safe and appropriate use of this medication.
Papaverine HCl 300 mg Slow Release Capsules are a specialized prescription medication designed to treat a range of conditions, including erectile dysfunction, Raynaud's phenomenon, and spasms of the bladder, intestines, and bile ducts. The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, papaverine hydrochloride, over an extended period of time.
This slow release mechanism offers several benefits. It allows for a more consistent therapeutic effect, reducing the risk of side effects often associated with sudden, high concentrations of medication in the body. It also reduces the frequency of dosing, which can improve patient compliance, particularly for those on long-term medication regimes.
When used as directed, Papaverine HCl 300 mg Slow Release Capsules can enhance blood flow to the penis, aiding in the improvement of erectile function. Additionally, it can alleviate spasms in the bladder, intestines, and bile ducts, and mitigate the frequency and severity of Raynaud's phenomenon episodes.
It is crucial to adhere to the prescribed dosage and frequency provided by your healthcare provider when taking Papaverine HCl 300 mg Slow Release Capsules. Avoid taking more or less than the recommended dose, and do not exceed the prescribed frequency. It's also important to inform your doctor about any other medications you are currently taking, as potential interactions could occur with Papaverine HCl 300 mg Slow Release Capsules.
If you have any queries or concerns about Papaverine HCl 300 mg Slow Release Capsules, please do not hesitate to reach out. It's important to fully understand how this medication works and how it can assist in managing your specific condition.
Papaverine HCl 300 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure that the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow-release formulation, the frequency of dosing is typically reduced compared to other formulations.
'Improved patient compliance' means that patients are more likely to take their medication as prescribed. This is because the slow-release formulation reduces the frequency of dosing, making it more convenient for patients.
No, the slow-release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period of time.
No, you should not break or crush the capsules. Doing so can interfere with the controlled-release mechanism and may lead to a sudden release of the medication, which can have adverse effects.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
If you accidentally take more than the prescribed dose, seek medical attention immediately. Overdosing can lead to serious health complications.
Before starting any new medication, you should always inform your doctor about any other medications you are currently taking. This includes prescription medications, over-the-counter drugs, and any supplements. Your doctor will be able to advise you on potential interactions and adjust your medication regimen if necessary.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
